YpsoLoop wins CPHI Pharma Award for Drug Delivery and Device Innovation

Ypsomed is proud to announce that its YpsoLoop autoinjector has been named the winner in the “Drug Delivery and Device Innovation” category at the CPHI Pharma Awards 2025 in Frankfurt. The award recognizes groundbreaking achievements that advance patient care in drug delivery.

Hailed as “revolutionary” by the award presenter, YpsoLoop was celebrated for uniting sustainability and patient convenience in one innovative platform.

“This award is a testament to our teams’ relentless drive to make self-care simpler, easier, and more sustainable,” said Rolf Gerber, Manager Marketing at Ypsomed. “YpsoLoop reflects what can be achieved when engineering excellence and environmental responsibility go hand in hand.”

The Drug Delivery and Device Innovation award is one of the most competitive categories at CPHI, honoring technologies that set new benchmarks for patient usability and design impact. This year’s award also reflects the growing importance of sustainability as a core criterion for innovation in drug delivery.

This recognition highlights the collaboration and dedication of Ypsomed’s cross-functional teams – from innovation to sustainability experts – whose collective expertise and hard work brought YpsoLoop from concept to reality. Looking ahead, Ypsomed remains committed to working with partners across the industry to advance sustainable, patient-centered solutions that make a lasting impact.